This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

R. K. Mosewich, MD; J. R. Donat, MD, FRCPC; S. DiMauro, MD; E. Ciafaloni, MD; S. Shanske, PhD; M. Erasmus, MD; D. George, MD, FRCPC

Arch Neurol. 1993;50(3):275-278.

Abstract
• Objective.
—To study and describe a large family with the tRNA Leu(UUR) point mutation at position 3243 in mitochondrial DNA, which is associated with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes.

Design.
—Survey; case series.

Setting.
—University hospital inpatient and outpatient neurology department.

Patients.
—Twelve patients from three generations in a family carrying the tRNA Leu(UUR) point mutation at position 3243 were studied.

Interventions.
—Clinical evaluation, muscle biopsy, and mitochondrial DNA point mutation quantitation of the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes in muscle and blood.

Main Outcome Measure.
—Correlation between clinical, pathologic, and genotypic features.

Results.
—Family members had various combinations of sensorineural hearing loss, retinal pigmentary degeneration, migraine, hypothalamic hypogonadism, and mild myopathy. Only one member had a strokelike episode at the age of 46 years. This patient had the highest point mutation percentage.

Conclusion.
—This report suggests that this point mutation may not be associated with stroke in all families and that whether patients develop stroke may depend on the percentage of mutant mitochondrial DNA and its tissue distribution.

Author Affiliations
From the Departments of Neurology (Drs Mosewich and Donat), Ophthalmology (Dr Erasmus), and Pathology (Dr George), Royal University Hospital, University of Saskatchewan, Saskatoon, and the H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Columbia Presbyterian Medical Center, New York, NY (Drs DiMauro, Ciafaloni, and Shanske).

Footnotes
Accepted for publication August 28, 1992.

Reprint requests to Department of Neurology, Royal University Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 0X0 (Dr Donat).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hearing Impairment Is Common in Various Phenotypes of the Mitochondrial DNA A3243G Mutation
Deschauer et al.
Arch Neurol 2001;58:1885-1888.
ABSTRACT | FULL TEXT  

Clinical mitochondrial genetics
Chinnery et al.
J. Med. Genet. 1999;36:425-436.
ABSTRACT | FULL TEXT  

A Case of Late-Onset MELAS
Kimata et al.
Arch Neurol 1998;55:722-725.
ABSTRACT | FULL TEXT  

Topical Review: Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes (MELAS): Current Concepts
Hirano and Pavlakis
J Child Neurol 1994;9:4-13.
ABSTRACT  

Variable Retinal and Neurologic Manifestations in Patients Harboring the Mitochondrial DNA 8993 Mutation
Ortiz et al.
Arch Ophthalmol 1993;111:1525-1530.
ABSTRACT